Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause

Fertility and Sterility

Volumn 90, Issue 6, 2008, Pages 2264-2268

  Zerbetto, Irene ^a   Gromoll, Jörg ^b   Luisi, Stefano ^a   Reis, Fernando M ^a   Nieschlag, Eberhard ^b   Simoni, Manuela ^b   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

DAZL; FSH receptor; menarche; menopause; SNP

Indexed keywords

ASPARAGINE; FOLLITROPIN RECEPTOR; SERINE;

ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; DAZL GENE; FEMALE; FEMALE FERTILITY; GENE; HUMAN; MENARCHE; MENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FERTILITY; GENOTYPE; HUMANS; MENARCHE; MENOPAUSE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, FSH; RNA-BINDING PROTEINS;

EID: 55749090118     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.036     Document Type: Article

References (31)

1. Meyer J.M., Eaves L.J., Heath A.C., and Martin N.G. Estimating genetic influences on the age-at-menarche: a survival analysis approach. Am J Med Genet 39 (1991) 148-154
2. Kaprio J., Rimpela A., Winter T., Viken R.J., Rimpela M., and Rose R.J. Common genetic influences on BMI and age at menarche. Hum Biol 67 (1995) 739-753
3. Carr B.R. Disorders of the ovaries and female reproductive tract. In: Wilson J.D., Forester D.W., Kronenberg H.M., and Carsen P.R. (Eds). Williams textbook of endocrinology. 9th ed. (1998), W.B. Saunders, New York 751-818
4. Tempfer C.B., Schneeberger C., and Huber J.C. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 5 (2004) 57-65
5. Gorai I., Tanaka K., Inada M., Morinaga H., Uchiyama Y., Kikuchi R., et al. Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. J Clin Endocrinol Metab 88 (2003) 799-803
6. Weel A.E., Uitterlinden A.G., Westerndop I.C., Burger H., Schuit S.C., Hofman A., et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 84 (1999) 3146-3150
7. Zheng W., Magid M.S., Kramer E.E., and Chen Y.T. Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 148 (1996) 47-53
8. Simoni M., Gromoll J., and Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophisiology. Endocr Rev 18 (1997) 739-773
9. Simoni M., Gromoll J., Höppner W., Kamischke A., Krafft T., Stähle D., et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 84 (1999) 751-755
10. Perez-Mayorga M., Gromoll J., Behre H.M., Gassner C., Nieschlag E., and Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulating depends on the FSH receptor genotype. J Clin Endocrinol Metab 85 (2000) 3365-3369
11. Behre H.M., Greb R.R., Mempel A., Sonntag B., Kiesel L., Kaltwasser P., et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenomics 15 (2005) 451-456
12. Greb R.R., Grieshaber K., Gromoll J., Sonntag B., Nieschlag E., Kiesel L., et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 90 (2005) 4866-4872
13. Reijo R.A., Dorfman D.M., Slee R., Renshaw A.A., Loughlin K.R., Cooke H., et al. DAZL family proteins exists throughout male germ cell development and transit from nucleus to cytoplasm at meiosis in humans and mice. Biol Reprod 63 (2000) 1490-1494
14. Xu E.Y., Moore F.L., and Reijo R.P. A gene family required for human germ cell development evolved from an ancient meiotic gene conserved in metazoans. Proc Natl Acad Sci U S A 98 (2001) 7414-7419
15. Lin Y.M., Chen C.W., Sun H.S., Tsai S.J., Lin J.S., and Kuo P.L. Presence of DAZL transcript and protein in mature human spermatozoa. Fertil Steril 77 (2002) 626-629
16. McNeilly J.R., Saunders P.T., Taggart M., Cranfield M., Cooke H.J., and McNeilly A.S. Loss of oocytes in Dazl knockout mice results in maintained ovarian steroidogenic function but altered gonadotropin secretion in adult animals. Endocrinology 141 (2000) 4284-4294
17. Tung J.Y., Rosen M.P., Nelson L.M., Turek P.J., Witte J.S., Cramer D.W., et al. Variants in Deleted in AZoospermia-Like (DAZL) are correlated with reproductive parameters in men and women. Hum Genet 118 (2006) 730-740
18. Teng Y.N., Lin Y.M., Lin H.M., Tsao S.Y., Hsu C.C., Lin S.J., et al. Association of a single nucleotide polymorphism of the DAZL gene with susceptibility to spermatogenic failure. J Clin Endocrinol Metab 87 (2002) 5258-5264
19. Ahda Y., Gromoll J., Wunsch A., Asatiani K., Zitzmann M., Nieschlag E., et al. FSH receptor gene haplotype distribution in normozoospermic and azoospermic men. J Androl 26 (2005) 494-499
20. Wunsch A., Ahda Y., Banaz-Yasar F., Sonntag B., Nieschlag E., Simoni M., et al. Single nucleotide polymorphism in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril 84 (2005) 446-453
21. Tschanter P., Kostova E., Lutjens C.M., Cooper T.G., Nieschlag E., and Gromoll J. No association of the A260G and A386g DAZL single nucleotide polymorphisms with male infertility in a Caucasian population. Hum Reprod 19 (2004) 2771-2776
22. Machin D., Campbell M., Fayers P., and Pinol A. Sample size tables for clinical studies. 2nd ed. (1997), Blackwell Science, Malden, MA
23. Asatiani K., Gromoll J., Eckardstein S.V., Zitzmann M., Nieshlag E., and Simoni M. Distribution and function of FSH receptor genetic variants in normal men. Andrologia 34 (2002) 172-176
24. Sharma J.C. The genetic contribution to pubertal growth and development studied by longitudinal growth data on twins. Ann Hum Biol 10 (1983) 163-171
25. Treloar S.A., and Martin N.G. Age at menarche as a fitness trait. Nonadditive genetic variance detected in a large twin sample. Am J Hum Genet 47 (1990) 137-148
26. Van der Schouwn Y.t., Van der Graaf Y., Steyerberg E.W., Eijkemans M.J.C., and Banga J.D. Age at menopause as a risk factor for cardiovascular mortality. Lancet 347 (1996) 714-718
27. Falch J.A., and Sandvik L. Perimenopausal appendicular bone loss. A 10 year prospective study. Bone 11 (1990) 425-428
28. Cramer D.W. Epidemiology aspects of early menopause and ovarian cancer. Ann N Y Acad Sci 592 (1990) 363-375
29. Swan S.H. Hormone replacement therapy and the risk of reproductive cancer. J Psychosom Obstet Gynecol 18 (1997) 165-174
30. Kato I., Toniolo P., Akhmedkhanova A., Koenig K.L., Shore R., and Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 51 (1998) 1271-1276
31. Harlow B.L., and Signorello L.B. Factors associated with early menopause. Maturitas 35 (2000) 3-9